< Back to previous page
Researcher
Patrick Verschueren
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Projects
1 - 10 of 13
- Tailoring therapeutic strategies and complementary care for patients with rheumatoid arthritisFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mass spectrometry based immunoprofiling in rheumatoid arthritis patientsFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation of a multimodal screening program for interstitial lung disease in rheumatoid arthritis patientsFrom29 Sep 2021 → TodayFunding: FWO fellowships
- Complementarity determining region-based immunoprofiling of rheumatoid arthritis.From1 Jan 2021 → TodayFunding: FWO research project
- Development and clinical validation of a multiplexed massspectrometry- based assay to improve diagnosis of Rheumatoid ArthritisFrom1 Jan 2021 → 31 Dec 2022Funding: FWO Applied Biomedical Research (TBM)
- How can we optimise the treatment with rituximab for patients with Rheumatoid Arthritis in daily clinical practice?From9 Nov 2020 → 10 Nov 2021Funding: Other federal public and semi-governmental institutions
- Towards a more personalized approach of the ambulatory care for RA patients.From30 Sep 2020 → TodayFunding: FWO Strategic Basic Research Grant
- Immuno-profile-directed stratification of patients with rheumatoid arthritisFrom1 Oct 2018 → 30 Sep 2020Funding: IOF - Industrial Research Fund
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
- Biological characterization of autoantibodies associated with therapy response in rheumatoid arthritisFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project
Publications
1 - 10 of 158
- Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis(2023)
Authors: Patrick Verschueren
Pages: 468 - 475 - Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease Activity(2023)
Authors: Michaël Doumen, Diederik De Cock, Delphine Bertrand, Rene Westhovens, Patrick Verschueren
Pages: 758 - 767 - Correspondence on 'EULAR recommendations for a core data set for pregnancy registries in rheumatology'(2023)
Authors: Diederik De Cock, Delphine Bertrand, Veerle Stouten, Rene Westhovens, Patrick Verschueren
- Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis(2023)
Authors: Jean-Baptiste Vulsteke, Rita Derua, Daniel Engelbert Blockmans, Petra De Haes, Steven Vanderschueren, Kristl Claeys, Wim Wuyts, Patrick Verschueren, Ellen De Langhe, Xavier Bossuyt
- Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis(2023)
Authors: Luna Dillemans, Mieke Gouwy, Patrick Matthys, Xavier Bossuyt, Patrick Verschueren, Carine Wouters, Lien De Somer, Paul Proost
- The future of polymyalgia rheumatica research: What can we learn from rheumatoid arthritis?(2023)
Authors: Lien Moreel, Michaël Doumen, Daniel Engelbert Blockmans, Patrick Verschueren, Steven Vanderschueren
Pages: 105529 - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update(2023)
Authors: Patrick Verschueren, Rene Westhovens
Pages: 3 - 18 - Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis(2023)
Authors: Patrick Verschueren
Pages: 81 - 94 - Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis(2023)
Authors: Patrick Verschueren
Pages: 95 - 106 - Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis(2023)
Authors: Patrick Verschueren
Pages: 107 - 118